Related Experiment Video
Updated: Jan 1, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Melanoma migration is promoted by prion protein via Akt-hsp27 signaling axis
Jingru Ke1, Guiru Wu2, Jie Zhang3
1Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, State Key Laboratory of Respiratory Diseases, 78 Hengzhigang Road, Guangzhou, 510095, China.
Abstract:
Patients with metastatic melanoma have a poorer prognosis. Prion protein (PrP) in melanoma is known to play an important role in cancer cell migration and invasion by interacting with filamin A (FLNa), a cytolinker protein. To investigate if PrP may contribute to cancer cell mobility independent of its binding to FLNa, we knocked out PRNP in M2 melanoma cell, which lacked FLNa expression. We found that deletion of PRNP in M2 significantly reduced its motility. When PRNP was deleted, the level of Akt was decreased. As a consequence, phosphorylation of small heat shock protein (hsp27) was also reduced, which resulted in polymerization of F-actin rendering the cells less migratory. Accordingly, when PrP was re-expressed in PRNP null M2 cells, the mobility of the recurred cells was rescued, so were the expression levels of Akt and phosphorylated hsp27, resulting in a decrease in the polymerization of F-actin. These results revealed that PrP can play a FLNa independent role in cytoskeletal organization and tumor cell migration by modulating Akt-hsp27-F-actin axis.
Insights
Prion protein (PrP) significantly reduces melanoma cell migration by modulating the Akt-hsp27-F-actin pathway, independent of filamin A. This finding offers new insights into metastatic melanoma progression.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Metastatic melanoma presents a significant clinical challenge with poor patient prognosis.
- Prion protein (PrP) is implicated in melanoma cell migration and invasion, partly through interaction with filamin A (FLNa).
Purpose of the Study:
- To investigate the role of PrP in melanoma cell mobility independently of its interaction with FLNa.
- To elucidate the molecular mechanisms by which PrP influences cell migration.
Main Methods:
- Utilized CRISPR-Cas9 to knock out the PRNP gene in M2 melanoma cells, which naturally lack FLNa expression.
- Assessed cell motility, protein expression levels (Akt, phosphorylated hsp27), and F-actin polymerization.
- Re-expressed PrP in PRNP-null cells to confirm findings.
Main Results:
- PRNP deletion significantly reduced M2 melanoma cell motility.
- PrP deficiency led to decreased Akt levels and reduced phosphorylation of small heat shock protein (hsp27).
- This resulted in altered F-actin polymerization, hindering cell migration.
Conclusions:
- Prion protein (PrP) plays a crucial role in cytoskeletal organization and tumor cell migration in melanoma, independent of FLNa.
- PrP modulates cell motility through the Akt-hsp27-F-actin signaling axis.
- Targeting PrP may offer a therapeutic strategy for metastatic melanoma.
Related Concept Videos
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation

